In a study carried out by Wang et al., ADAM9 was overexpressed in GC tissues, and its high levels were significantly correlated with more advanced GC clinicopathological features, such as local advancement and metastasis, described in the TNM system. This evidence concerns the gene ADAM9 and gastric cancer.